CD5 and neoplasm: The increased level of CD5 on T cells upon TCR/CD3 stimulation by monoclonal antibody treatment (25) or by exposure to poorly immunogenic 4T1 tumor antigen reported here suggests that CD5 level may be directly increased by that activation.